A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause. Menopause can accelerate age-related weight gain and increase the likelihood of...
Author: Derek Bagley
New Directions in Thyroid Care: Minimizing Risk, Maximizing Choice
From how radioiodine therapy for Graves’ disease impacts cancer occurrence and the potential usefulness of pharmacologic treatment for benign thyroid nodules to how a minimally invasive procedure could be the preferred treatment option, recent studies from The Journal of Clinical Endocrinology & Metabolism further demonstrate how endocrine science is benefiting patients around the world. As...
For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025. From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers! For more...Quality Time: How Endocrine Society Journals Continue to Maintain the Highest Standards Possible
Scientific journal integrity is increasingly being threatened with the rise of predatory journals, fraudulent papers, and even nonsensical submissions. On January 28 this year the Endocrine Society released a statement warning members against solicitations from a journal called “Journal of Endocrinology and Metabolism.” The Society cannot verify the authenticity or accuracy of this “journal” with...
Tirzepatide Improves Blood Sugar Control in Children Aged 10-17 Years with Type 2 Diabetes
New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both. The study (the SURPASS-PEDS trial), led...
Omodamola Aje, MD, has built a social media platform to provide women with the tools they need to ask their doctors informed questions and help guide decisions in their treatment, from menopause to hypothyroidism. Aje is using her platform to not only help build a sense of community, but to cut through the rampant misinformation...
Challenges and Opportunities: Developing New and Improved Treatment Options for Type 1 Diabetes
A recently published Scientific Statement sheds light on new and improved treatment options for type 1 diabetes. Endocrine News speaks with first author Aaron W. Michels, MD, about the Statement’s implications and why this is an exciting time in type 1 diabetes research. In July, the Endocrine Society published a Scientific Statement that highlights potential...
String of Pearls: A Look at Rare Clinical Pearls from JCEM Case Reports
The JCEM Case Reports Clinical Pearls session at ENDO 2025 featured three presentations of rare challenging endocrine cases that could answer questions for endocrinologists who could be treating patients with similar symptoms, possibly triggering further investigations that might lead to optimal outcomes. The audience for the third-annual JCEM Case Reports Clinical Pearls session at ENDO...
